The Neurocognitive Effects of Aging with HIV Effects of combination antiretroviral therapy along with HIV-induced inflammation, lifestyle, and physical and mental comorbidities have all played

Oregon State Legislature to Allow Pharmacists to Prescribe PrEP and PEP drugs Along the lines of expanding access to (and better utilization of) routine care

Washington State Legislature Moves to Address Medicaid Drug Access and creates STI/PrEP/PEP Workgroup In Washington state (WA), a collective sense of relief was felt when

May is Hepatitis Awareness Month The most common types of viral hepatitis in the US are Hepatitis A, B, and C. According to the Centers

Biden Administration Reinstates ACA Protections for Transgender and All LGBTQ People On Monday, May 10th, the Biden administration reinstated Obama-era protections included in the Patient

TennCare III Medicaid Program – April 2021 On January 8, 2021, CMS approved a waiver request from Tennessee that transitions nearly all of its TennCare

Gilead Sciences Proposes Change to Patient Assistance Program – April 2021 On April 8th, Gilead Sciences (Gilead) proposed a change to its Advancing Access Patient

A Freeze on the Trump-Era Drug “Rebate Rule” Stalls – April 2021 In recent years, the federal government has called for increased review (and transparency)

CMS Administrator Nomination Stalls – April 2021 The confirmation of President Joe Biden’s nomination to lead the Centers for Medicare & Medicaid Services (CMS) was